http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03106967-A9
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9af53a5980f032698334e6592d1c51d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a95795afb72de5fbfb45600bcf80aee4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b481c61ea03fcfba51558bf7937d3d36 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2003-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_107e28727c6f586c81eecb95ec29f08e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc73d84c8a6cc523e4c3e456e13baed9 |
| publicationDate | 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-03106967-A9 |
| titleOfInvention | METHOD FOR ASSESSING MYELODEPRESSIVE CONDITION |
| abstract | The present invention relates to kits and methods for assessing the myelosuppressive condition of a patient. These methods and kits are a useful complement to myelosuppressive therapies. The establishment of threshold levels of certain cytokines as a substitute for bone marrow aplasia or by the use of normal rates for assessing the state of a patient's bone marrow, treatment protocols that can be improved with a view to reduce myelotoxicity, while maximizing the effective dose. Furthermore, the invention relates to kits and methods which can be used to regulate the dose of myelosuppressive agents or immunomodulators to be administered to a patient, while the level of a hematopoietic cytokine in a patient sample is compared to a normal rate, before and / or after administration of the dose. |
| priorityDate | 2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 369.